Mendonça Junior, F. J. B.
Publications
P310
Bioorg. Chem. 2026, 176, 109839.
Insights into a new class of antileishmanial compounds: an in vitro and in silico study of 1,2,4-oxadiazol-5(4H)-one derivatives.
https://doi.org/10.1016/j.bioorg.2026.109839
P309
Bioorg. Med. Chem. 2026, 139, 118678.
5,6,7,8-Tetrahydroimidazo[1,2-a]pyrazine-based thiosemicarbazones as anti-Trypanosoma cruzi agents.
https://doi.org/10.1016/j.bmc.2026.118678
P204
Med. Chem. Commun. 2019, 10, 1916-1925.
Evaluation of anti-inflammatory activity and molecular docking study of new aza-bicyclic isoxazoline acylhydrazone derivatives.
doi: 10.1039/c9md00276f
P203
Int. Immunopharmacol. 2019, 76, 105856.
Synthesis and pharmacological evaluation of CVIB, a codrug of carvacrol and ibuprofen as a novel anti-inflammatory agent.
doi:10.1016/j.intimp.2019.105856
P199
Curr. Top. Med. Chem. 2019, 19, 1075-1091.
5-Nitro-thiophene-thiosemicarbazone derivatives present antitumor activity mediated by apoptosis and DNA intercalation.
doi: 10.2174/1568026619666190621120304
Autres publications scientifiques
Brevets
Thèse